Clinical application of immunologic adjustment using mixed lymphocyte reaction using a carboxyfluorescein diacetate succinimidyl ester labeling technique

Clinical application of immunologic adjustment using mixed lymphocyte reaction using a carboxyfluorescein diacetate succinimidyl ester labeling technique - Immunologic adjustment using mixed lymphocyte reaction

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007462

Enrollment

100

Registered

2012-03-07

Start date

2012-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing liver transplantation

Interventions

We analyze immunstatus of patients using CSFE-MLR and adjust immunosuppression based on the result.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients of 16-year old or older who understand and agree to enrollment to this study after fully informed consent.

Exclusion criteria

Exclusion criteria: Patients undergoing deceased donor liver transplantation

Design outcomes

Primary

Measure	Time frame
Incidence of withdrawal of immunosuppression 5 years after transplantation	—

Secondary

Measure	Time frame
Incidence of rejection within 1 year after transplantation	—

Countries

Japan

Contacts

Public ContactHiroto Egawa

Tokyo Women's Medical University Institute of Gastroenterology

egawa@ige.twmu.ac.jp03-3353-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026